As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.
Cancer is a complex condition marked by the uncontrolled growth of cells in the body. When this process begins in the lungs, ...
The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...
Joe Leach, MD, discusses some of the latest developments in incorporating immunotherapy into small cell lung cancer treatment regimens.